CSIMarket Company Name, Ticker, Customers, else..
 
Oncotelic Therapeutics Inc   (OTLC)
 
Price: $0.0300 $0.00 0.000%
Day's High: $0.03200000151991844 Week Perf: 0.00
Day's Low: $ 0.03 30 Day Perf: 0.00
Volume (M): 225,965 52 Wk High: $ 0.11
Volume (M$): $ 0 52 Wk Avg: $0.06
Open: $0.03 52 Wk Low: $0.02



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 468
 Employees 38
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 247
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Oncotelic Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative therapies for the treatment of cancer. The company's primary goal is to create targeted drugs that can effectively inhibit the growth and spread of cancer cells while minimizing the side effects often associated with traditional chemotherapy. Oncotelic Therapeutics utilizes advanced technologies, including nanomedicine and RNA interference, to design and develop its drug candidates. These novel therapies aim to improve patient outcomes and provide new solutions in the field of oncology.


   Company Address: 29397 Agoura Road Suite 107 Agoura Hills 91301 CA
   Company Phone Number: 635-7000   Stock Exchange / Ticker: OTLC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARDX   -0.26%    
ISCO        20% 
OVID        3% 
SBFM        2.68% 
SNDX        3.37% 
URGN        1.68% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 0.05
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 56.15
Price to Sales (Expected) -
Price to Book 0.05
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.01
Working Capital Ratio 0.08
Leverage Ratio (MRQ) 0.49
Total Debt to Equity 0.02
Interest Coverage (TTM) 467.28
Debt Coverage (TTM) 75.64

Per Share Current
Earnings (TTM) 0.59 $
Revenues (TTM) 0 $
Cash Flow (TTM) -
Cash 0 $
Book Value 0.57 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 6,579
Net Income per Employee (TTM) 6,507,381
Receivable Turnover Ratio (TTM) 16.83
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -337.43 %
Net Margin (MRQ) 136.4 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 31.12 %

Management Effectiveness Current
Return On Assets (TTM) 81.75 %
Return On Investment (TTM) 87.35 %
Return On Equity (TTM) 124.17 %
Dividend Yield -
Pay out Ratio (TTM) -



Oncotelic Therapeutics Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.